The thing about the FDA letter that most bothers m
Post# of 148252
(Total Views: 460)
Posted On: 05/19/2021 3:42:45 PM
The thing about the FDA letter that most bothers me, is that because of the wording and untrue statements, it gives one the perspective that they literally intended to attack and thus, the FDA "must be" against Cytodyn. This supports the conspiracy theories, Gilead, BP etc.
Example....
CD10:
1) "Clinical Significance" achieved on Primary Endpoint
2) "Statistical Significance" achieved on Secondary Endpoint NEWS2
FDA Letter:
CD10 no effect from leronlimab on Primary nor Secondary Endpoints
Example....
CD10:
1) "Clinical Significance" achieved on Primary Endpoint
2) "Statistical Significance" achieved on Secondary Endpoint NEWS2
FDA Letter:
CD10 no effect from leronlimab on Primary nor Secondary Endpoints
(8)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼